Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma

Overview of attention for article published in Respiratory Research, April 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 14 X users
patent: 1 patent

video: 1 YouTube creator

Citations

dimensions_citation: 89 Dimensions

Readers on

mendeley: 101 Mendeley

Summary X Patents YouTube Dimensions citations

So far, Altmetric has seen 17 X posts from 14 X users, with an upper bound of 12,490 followers.

RT @AimHardy: @HighPointInvest @BlogShrey @Brabo83 @LRamseu Many thanks for the mention High Point For investors interested in my researc…

30 Nov 2021

Reply Repost Favourite

@HighPointInvest @BlogShrey @Brabo83 @LRamseu Many thanks for the mention High Point For investors interested in my research it is all compiled in this thread #DDDD $LBPS 💊 Bottom up ⬆️

29 Nov 2021

Reply Repost Favourite

RT @AimHardy: #DDDD $LBPS 💊 🚨INDEPENDENT PUBLICATION🚨 Bifidobacterium breve (MRx0004) is as effective as Budesonide- A 2017 FDA approve…

21 Nov 2021

Reply Repost Favourite

RT @AimHardy: #DDDD $LBPS 💊 🚨INDEPENDENT PUBLICATION🚨 Bifidobacterium breve (MRx0004) is as effective as Budesonide- A 2017 FDA approve…

21 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.